* BioLife Solutions Inc BLFS.OQ reported a quarterly
adjusted
loss of 19 cents per share for the quarter ended in March. The
mean expectation of eight analysts for the quarter was for a
loss of 25 cents per share.
* Revenue rose 115% to $36.22 million from a year ago;
analysts
expected $38.20 million.
* BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 17 cents.
* The mean earnings estimate of analysts had fallen by
about 89.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BioLife Solutions Inc shares had fallen by 46.2% this
quarter and lost 67.2% so far this year.
* The company reported a quarterly loss of $7.07 million.
* Wall Street's median 12-month price target for BioLife
Solutions
Inc is $55.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated May 9 at 10:02 p.m. All
figures in US dollars unless otherwise stated